Impact of MYC-R on the outcome of LS DLBCL patients
Vera De Jonge, PhD student from the VUMC, Amsterdam and Johanna Bult, PhD student from the University Medical Center Groningen assessed the impact of a rearrangement of the MYC oncogene on the outcome of patients with stage I or II diffuse large B-cell lymphoma in the Netherlands.
With the educational support of:
![](https://usercontent.one/wp/medimix.be/wp-content/uploads/sites/5/2023/06/supported-by-icml-2023.png)